Business
Vivos Therapeutics Opens State of the Art International Training Center In Denver
The Vivos Institute Is Expected to Significantly Increase Vivos’ Ability to Educate Healthcare Providers on Ways to Help Millions of People Suffering from
About this update from Vivos Therapeutics, Inc.
[{"type":"text","content":"The Vivos Institute Is Expected to Significantly Increase Vivos’ Ability to Educate Healthcare Providers on Ways to Help Millions of People Suffering from Sleep Apnea and its Comorbidities\nHIGHLANDS RANCH, Colo., July 29, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today announced that the Company has opened The Vivos Institute training center in Denver, Colorado. The 15,000-square-foot facility was established to provide advanced post-graduate education and training to dentists, dental teams and other healthcare providers from around the world in a live and hands-on setting. The Institute’s emphasis will be on educating healthcare providers about OSA and Vivos’ treatments for OSA within their practice areas, along with training on Vivos’ related practice management tools for dentists. “Part of our mission is to spread the word about OSA among healthcare professionals who can help treat it. This new facility can accommodate 300 to 400 healthcare professionals a day, which not only significantly increases our clinical training capacity but also enables us to leverage the technology that we’ve built into the center to provide the highest-quality training for dentists all over the country and the world,” said Kirk Huntsman, Vivos Chairman and CEO. “The Institute’s opening (which augments the online training we established over the last year and half) represents a critical milestone for us as we train independent dentists whose patients suffer from dentofacial malformations that may be associated with OSA and other debilitating health conditions. We are also proud that we are able to open our Vivos Institute as promised with the proceeds of our initial public offering that occurred just eight months ago.” In support of this facility and its mission, several dental and medical supply companies donated over $500,000 in equipment for the center. For more information about the grand opening of the Vivos Institute, please visit: https://thevivosinstitute.com/grand-opening/ About Vivos Therapeutics, Inc. Vivos Therapeutics Inc. (NASDAQ: VVOS) is a medical techno...